Medications and treatments are always being researched and developed to treat diseases, including allergies and asthma. Dr. James Sublett recently spoke to The Wall Street Journal on the longstanding asthma treatment options.
Our allergists understand the differences between the different kinds of patients that we see in our offices. A new study in the New England Journal of Medicine took a closer look at patients with mild, persistent asthma who did no better using a steroid inhaler than with a placebo.
Hear what Dr. Sublett had to say in the full article: New Thinking on Longstanding Asthma Treatments